IGFBP2 and fatty liver disease: In this study, we explored the correlation between serum IGFBP2 levels and the severity of hepatic steatosis measured by the controlled attenuation parameter (CAP) in adult patients with MASLD, aiming to provide new insights for the development of potential strategies for the diagnosis and treatment of MASLD.